GLP-1 Agonist weight loss injections represent a significant advancement in medical weight management, offering real hope for individuals committed to improving their health
His central claim is that carbohydrates, especially sugar and high-fructose corn syrup, overstimulate the secretion of insulin, causing the body to store fat in fat cells and the liver, and that it is primarily a high level of dietary carbohydrate consumption that accounts for obesity and other metabolic syndrome conditions
The study found that when patients experienced greater weight loss, they were less likely to discontinue the GLP-1 RA medications
Still, this is the longest guarantee weve seen in the space
Because if this market really grows 10x in a decade, its not just about pharma making more money
The HHS General Counsel announced on X that his agency had referred Hims & Hers to the Department of Justice for potential violations of the Federal Food, Drug, and Cosmetic Act and applicable criminal provisions